 ANDOVER, Mass., June 8, 2021 PRNewswire -- TransMedics Group, Inc. TransMedics Nasdaq: TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that the complete results of the OCSTM Liver PROTECT Trial PROTECT were presented virtually at the American Transplant Congress on Tuesday June 8 th, 2021. 